Analyzing Ratios: Universal Technical Institute Inc (UTI)’s Financial Story Unveiled

The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.

The price of Universal Technical Institute Inc (NYSE: UTI) closed at $34.29 in the last session, down -2.92% from day before closing price of $35.32. In other words, the price has decreased by -$2.92 from its previous closing price. On the day, 1.11 million shares were traded.

Ratios:

We take a closer look at UTI’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 13.31 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 26.32. For the most recent quarter (mrq), Quick Ratio is recorded 1.07 and its Current Ratio is at 1.07. In the meantime, Its Debt-to-Equity ratio is 0.87 whereas as Long-Term Debt/Eq ratio is at 0.79.

On July 25, 2024, Truist started tracking the stock assigning a Buy rating and target price of $22.

On January 10, 2024, Northland Capital started tracking the stock assigning a Outperform rating and target price of $16.Northland Capital initiated its Outperform rating on January 10, 2024, with a $16 target price.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 15 ’25 when Hitchcock Todd A sold 27,500 shares for $33.36 per share. The transaction valued at 917,471 led to the insider holds 80,521 shares of the business.

Brochick George W. sold 6,000 shares of UTI for $191,040 on May 13 ’25. The Director now owns 32,516 shares after completing the transaction at $31.84 per share. On May 15 ’25, another insider, Hitchcock Todd A, who serves as the Officer of the company, bought 27,500 shares for $33.36 each.

Valuation Measures:

As of this moment, Universal’s Price-to-Earnings (P/E) ratio for their current fiscal year is 33.07, and their Forward P/E ratio for the next fiscal year is 32.18. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.95. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.38 while its Price-to-Book (P/B) ratio in mrq is 6.35.

Stock Price History:

Over the past 52 weeks, UTI has reached a high of $35.99, while it has fallen to a 52-week low of $13.66. The 50-Day Moving Average of the stock is 19.40%, while the 200-Day Moving Average is calculated to be 46.10%.

Shares Statistics:

A total of 54.41M shares are outstanding, with a floating share count of 50.27M. Insiders hold about 7.61% of the company’s shares, while institutions hold 88.01% stake in the company.

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.